Current alternative and complementary therapies used in menopause
- 1 January 2009
- journal article
- review article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 25 (3) , 166-174
Abstract
Objective. To determine the efficacy and safety of common complementary and alternative medicine (CAM) therapies used to relieve the menopausal symptoms. Design. Comprehensive literature search was conducted through the databases Medline, EMBASE, Cochrane, AMED (Allied and Complementary Medicine), NCCAM (The National Centre for Complementary and Alternative Medicine) to identify relevant monographs in English language. Results. Studies have shown that some therapies such as clonidine, selective serotonin receptor inhibitors (SSRIs) and gabapentin are effective in decreasing the degree and frequency of somatic symptoms in menopause, while phytooestrogens and black cohosh have shown mixed results. Use of Ginseng, evening primrose, Dong Quai or vitamin E appears not to be efficacious for the relieving hot flushes. Other effects of these therapies including possible improvements in mood are yet to be substantiated. Inclusion criteria. All available human complementary medicine studies on menopausal women with regard to the relief of menopausal symptoms. Exclusion criteria. Studies not meeting the inclusion criteria, published in languages other than English or animal studies. Conclusion. There is a general lacking of longer-term follow-up beyond the trial lengths of 6–12 weeks in the use of CAM, although women may be taking these medications for many years. Well-designed, randomised control trials are needed to elucidate the true effect of these therapies above the placebo effect.Keywords
This publication has 71 references indexed in Scilit:
- Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based reviewArchives of Gynecology and Obstetrics, 2007
- Contemporary alternatives to plant estrogens for menopauseMaturitas, 2006
- Progesterone metabolites in breast cancerEndocrine-Related Cancer, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohortInternational Journal of Cancer, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Evidence from randomised trials on the long-term effects of hormone replacement therapyThe Lancet, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Smoking and Age at Menopause in WomenAnnals of Internal Medicine, 1985